Market Tracker

07/22 5:16pm ET

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY)

65.49
Delayed Data
As of Jul 22
 +0.52 / +0.80%
Today’s Change
49.96
Today|||52-Week Range
136.28
-30.43%
Year-to-Date
No recent news for Alnylam Pharmaceuticals Inc.

Today’s Trading

Previous close64.97
Today’s open65.24
Day’s range64.58 - 65.85
Volume770,778
Average volume (3 months)923,305
Market cap$5.6B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+28.87%
Earnings growth (this year)-44.42%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-18.72%
P/E ratioNM
Price/Sales192.40
Price/Book4.41

Competitors

 Today’s
change
Today’s
% change
CRLCharles River Labora...+0.77+0.90%
ICLRICON PLC+1.08+1.52%
PRXLPAREXEL Internationa...+0.62+0.96%
IONSIonis Pharmaceutical...+0.09+0.32%
Data as of 4:02pm ET, 07/22/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$1.25
Annual revenue (last year)$41.1M
Annual profit (last year)-$290.1M
Net profit margin-705.83%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John M. Maraganore
President &
Chief Operating Officer
Barry E. Greene
Corporate headquarters
Cambridge, Massachusetts

Forecasts